Published in Front Microbiol on March 12, 2012
Myeloid suppressor cells require membrane TNFR2 expression for suppressive activity. Immun Inflamm Dis (2014) 0.83
Leishmania spp. Proteome Data Sets: A Comprehensive Resource for Vaccine Development to Target Visceral Leishmaniasis. Front Immunol (2014) 0.78
MIF Promotes Classical Activation and Conversion of Inflammatory Ly6C(high) Monocytes into TipDCs during Murine Toxoplasmosis. Mediators Inflamm (2016) 0.76
Visceral leishmaniasis relapse in HIV patients--a role for myeloid-derived suppressor cells? PLoS Negl Trop Dis (2014) 0.75
Leishmanicidal Activity of Piper nigrum Bioactive Fractions is Interceded via Apoptosis In Vitro and Substantiated by Th1 Immunostimulatory Potential In Vivo. Front Microbiol (2015) 0.75
Divergent roles for Ly6C+CCR2+CX3CR1+ inflammatory monocytes during primary or secondary infection of the skin with the intra-phagosomal pathogen Leishmania major. PLoS Pathog (2017) 0.75
Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol (2009) 25.96
An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J Immunol Methods (1999) 17.06
Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution. J Exp Med (1973) 13.88
Nitric oxide and macrophage function. Annu Rev Immunol (1997) 12.77
Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2. Nat Immunol (2006) 11.06
Mouse and human dendritic cell subtypes. Nat Rev Immunol (2002) 10.01
Regulation of immune responses by L-arginine metabolism. Nat Rev Immunol (2005) 9.27
Subsets of myeloid-derived suppressor cells in tumor-bearing mice. J Immunol (2008) 9.25
Plasmacytoid dendritic cells in immunity. Nat Immunol (2004) 9.11
Blood monocytes: development, heterogeneity, and relationship with dendritic cells. Annu Rev Immunol (2009) 8.67
Subpopulations of mouse blood monocytes differ in maturation stage and inflammatory response. J Immunol (2004) 8.65
TNF/iNOS-producing dendritic cells mediate innate immune defense against bacterial infection. Immunity (2003) 7.33
Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity. Blood (2008) 7.15
Gr-1+CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host. Cancer Res (2006) 7.02
A clonogenic bone marrow progenitor specific for macrophages and dendritic cells. Science (2005) 5.88
Macrophage receptors and immune recognition. Annu Rev Immunol (2005) 5.83
Antigen-specific inhibition of CD8+ T cell response by immature myeloid cells in cancer is mediated by reactive oxygen species. J Immunol (2004) 5.73
Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer. Nat Med (2007) 5.65
Dynamic imaging of T cell-dendritic cell interactions in lymph nodes. Science (2002) 5.61
Langerhans cells arise from monocytes in vivo. Nat Immunol (2006) 5.46
Origin of dendritic cells in peripheral lymphoid organs of mice. Nat Immunol (2007) 5.31
In vivo imaging reveals an essential role for neutrophils in leishmaniasis transmitted by sand flies. Science (2008) 5.09
Imaging the single cell dynamics of CD4+ T cell activation by dendritic cells in lymph nodes. J Exp Med (2004) 5.08
The receptor tyrosine kinase Flt3 is required for dendritic cell development in peripheral lymphoid tissues. Nat Immunol (2008) 4.86
CD11c(+)B220(+)Gr-1(+) cells in mouse lymph nodes and spleen display characteristics of plasmacytoid dendritic cells. J Exp Med (2001) 4.82
Monocyte-derived dendritic cells formed at the infection site control the induction of protective T helper 1 responses against Leishmania. Immunity (2007) 4.65
Activated granulocytes and granulocyte-derived hydrogen peroxide are the underlying mechanism of suppression of t-cell function in advanced cancer patients. Cancer Res (2001) 4.49
Arginine regulation by myeloid derived suppressor cells and tolerance in cancer: mechanisms and therapeutic perspectives. Immunol Rev (2008) 4.40
Origin, homeostasis and function of Langerhans cells and other langerin-expressing dendritic cells. Nat Rev Immunol (2008) 4.17
Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma. J Exp Med (2005) 3.80
Th1/Th2-regulated expression of arginase isoforms in murine macrophages and dendritic cells. J Immunol (1999) 3.68
Myeloid-derived suppressor cells promote cross-tolerance in B-cell lymphoma by expanding regulatory T cells. Cancer Res (2008) 3.57
CD11b+Ly-6C(hi) suppressive monocytes in experimental autoimmune encephalomyelitis. J Immunol (2007) 3.39
L-arginine availability regulates T-lymphocyte cell-cycle progression. Blood (2006) 3.17
Gr-1+ myeloid cells derived from tumor-bearing mice inhibit primary T cell activation induced through CD3/CD28 costimulation. J Immunol (2000) 3.07
Leishmaniasis: complexity at the host-pathogen interface. Nat Rev Microbiol (2011) 2.93
Macrophages as APC and the dendritic cell myth. J Immunol (2008) 2.90
Rapid recruitment of inflammatory monocytes is independent of neutrophil migration. Blood (2003) 2.88
Markers of mouse macrophage development detected by monoclonal antibodies. J Immunol Methods (1994) 2.85
Adhesion mechanisms regulating the migration of monocytes. Nat Rev Immunol (2004) 2.81
Tumor-infiltrating myeloid-derived suppressor cells are pleiotropic-inflamed monocytes/macrophages that bear M1- and M2-type characteristics. J Leukoc Biol (2008) 2.76
Increase in TNF-alpha and inducible nitric oxide synthase-expressing dendritic cells in psoriasis and reduction with efalizumab (anti-CD11a). Proc Natl Acad Sci U S A (2005) 2.47
Langerhans cells and more: langerin-expressing dendritic cell subsets in the skin. Immunol Rev (2010) 2.44
Subversion mechanisms by which Leishmania parasites can escape the host immune response: a signaling point of view. Clin Microbiol Rev (2005) 2.33
Macrophage-derived nitric oxide regulates T cell activation via reversible disruption of the Jak3/STAT5 signaling pathway. J Immunol (1998) 2.25
Type 1 interferon (IFNalpha/beta) and type 2 nitric oxide synthase regulate the innate immune response to a protozoan parasite. Immunity (1998) 2.22
Characterization of the nature of granulocytic myeloid-derived suppressor cells in tumor-bearing mice. J Leukoc Biol (2011) 2.06
TCR zeta down-regulation under chronic inflammation is mediated by myeloid suppressor cells differentially distributed between various lymphatic organs. J Immunol (2006) 2.05
Immunosuppression during acute Trypanosoma cruzi infection: involvement of Ly6G (Gr1(+))CD11b(+ )immature myeloid suppressor cells. Int Immunol (2002) 1.81
Monocytes: subsets, origins, fates and functions. Curr Opin Hematol (2010) 1.77
CD80+Gr-1+ myeloid cells inhibit development of antifungal Th1 immunity in mice with candidiasis. J Immunol (2002) 1.73
Tip-DC development during parasitic infection is regulated by IL-10 and requires CCL2/CCR2, IFN-gamma and MyD88 signaling. PLoS Pathog (2010) 1.70
Tumor-induced CD11b+Gr-1+ myeloid cells suppress T cell sensitization in tumor-draining lymph nodes. J Immunol (2008) 1.69
Immunity to cancer: attack and escape in T lymphocyte-tumor cell interaction. Immunol Rev (2002) 1.66
Regulatory T cells: history and perspective. Methods Mol Biol (2011) 1.64
Natural suppressor (NS) cells, neonatal tolerance, and total lymphoid irradiation: exploring obscure relationships. Annu Rev Immunol (1984) 1.61
Macrophages and dendritic cells constitute a major subpopulation of cells in the mouse dermis. J Invest Dermatol (2004) 1.60
The stromal and haematopoietic antigen-presenting cells that reside in secondary lymphoid organs. Nat Rev Immunol (2010) 1.60
NK cell activation in visceral leishmaniasis requires TLR9, myeloid DCs, and IL-12, but is independent of plasmacytoid DCs. J Exp Med (2007) 1.57
Fibroblasts as host cells in latent leishmaniosis. J Exp Med (2000) 1.54
iNOS-producing inflammatory dendritic cells constitute the major infected cell type during the chronic Leishmania major infection phase of C57BL/6 resistant mice. PLoS Pathog (2009) 1.53
Induction of nitric oxide synthase in mouse dendritic cells by IFN-gamma, endotoxin, and interaction with allogeneic T cells: nitric oxide production is associated with dendritic cell apoptosis. J Immunol (1996) 1.53
The immune response to Leishmania: mechanisms of parasite control and evasion. Int J Parasitol (1998) 1.51
Langerhans cells are negative regulators of the anti-Leishmania response. J Exp Med (2011) 1.49
TLR9 signaling is essential for the innate NK cell response in murine cutaneous leishmaniasis. Eur J Immunol (2007) 1.46
Differential expression of chemokines in patients with localized and diffuse cutaneous American leishmaniasis. J Infect Dis (1996) 1.44
Rapidly fatal leishmaniasis in resistant C57BL/6 mice lacking TNF. J Immunol (2001) 1.42
A modification of Jerne's theory of antibody production using the concept of clonal selection. CA Cancer J Clin (1976) 1.41
Dendritic cells, pro-inflammatory responses, and antigen presentation in a rodent malaria infection. Immunol Rev (2004) 1.36
Divergent expression of inflammatory dermal chemokines in cutaneous leishmaniasis. Parasite Immunol (2002) 1.34
Anatomic location and T-cell stimulatory functions of mouse dendritic cell subsets defined by CD4 and CD8 expression. Blood (2002) 1.31
Monocyte chemotactic protein-1 stimulates the killing of leishmania major by human monocytes, acts synergistically with IFN-gamma and is antagonized by IL-4. Eur J Immunol (2000) 1.30
Monocyte migration to inflamed skin and lymph nodes is differentially controlled by L-selectin and PSGL-1. Blood (2008) 1.21
Apoptotic cells induce immunosuppression through dendritic cells: critical roles of IFN-gamma and nitric oxide. J Immunol (2008) 1.21
CCR2 plays a critical role in dendritic cell maturation: possible role of CCL2 and NF-kappa B. J Immunol (2010) 1.20
Priming of CD8+ and CD4+ T cells in experimental leishmaniasis is initiated by different dendritic cell subtypes. J Immunol (2009) 1.13
Protection against progressive leishmaniasis by IFN-beta. J Immunol (2004) 1.12
Production of IFN-β during Listeria monocytogenes infection is restricted to monocyte/macrophage lineage. PLoS One (2011) 1.12
Analysis of the maturation process of dendritic cells deficient for TNF and lymphotoxin-alpha reveals an essential role for TNF. J Leukoc Biol (2003) 1.08
Are neutrophils important host cells for Leishmania parasites? Trends Parasitol (2009) 1.06
Nitric oxide inhibits the secretion of T-helper 1- and T-helper 2-associated cytokines in activated human T cells. Immunology (1997) 1.05
Myeloid-derived suppressor cells infiltrate the heart in acute Trypanosoma cruzi infection. J Immunol (2011) 1.05
Activated Langerhans cells release tumor necrosis factor. J Leukoc Biol (1989) 1.03
Cutting edge: B220+CCR9- dendritic cells are not plasmacytoid dendritic cells but are precursors of conventional dendritic cells. J Immunol (2009) 1.02
A fluorescence reporter model defines "Tip-DCs" as the cellular source of interferon β in murine listeriosis. PLoS One (2010) 1.02
Murine epidermal Langerhans cells are potent stimulators of an antigen-specific T cell response to Leishmania major, the cause of cutaneous leishmaniasis. Eur J Immunol (1992) 1.01
Myeloid-derived suppressor cells help protective immunity to Leishmania major infection despite suppressed T cell responses. J Leukoc Biol (2011) 1.01
Reactive oxygen species production by blood neutrophils of patients with laryngeal carcinoma and antioxidative enzyme activity in their blood. Acta Oncol (2004) 1.00
Nitric oxide production by mouse bone marrow-derived dendritic cells: implications for the regulation of allogeneic T cell responses. Transplantation (1996) 0.96
Secretory products of phagocytes. Curr Opin Immunol (1989) 0.95
Murine epidermal Langerhans cells do not express inducible nitric oxide synthase. Eur J Immunol (1996) 0.94
Differential expansion, activation and effector functions of conventional and plasmacytoid dendritic cells in mouse tissues transiently infected with Listeria monocytogenes. Cell Microbiol (2006) 0.94
Nitric oxide production by human macrophages: there's NO doubt about it. Am J Physiol Lung Cell Mol Physiol (2002) 0.93
Regulation of the expression of nitric oxide synthase by Leishmania mexicana amastigotes in murine dendritic cells. Exp Parasitol (2010) 0.92
Leishmania major parasite stage-dependent host cell invasion and immune evasion. FASEB J (2011) 0.92
Murine thymic plasmacytoid dendritic cells. Eur J Immunol (2003) 0.91
A new view on cutaneous dendritic cell subsets in experimental leishmaniasis. Med Microbiol Immunol (2006) 0.90
Accelerated dendritic cell differentiation from migrating Ly6C(lo) bone marrow monocytes in early dermal West Nile virus infection. J Immunol (2011) 0.88
Inducible nitric oxide synthase downmodulates contact hypersensitivity by suppressing dendritic cell migration and survival. J Invest Dermatol (2009) 0.88
TNF is important for pathogen control and limits brain damage in murine cerebral listeriosis. J Immunol (2006) 0.83
Antiretroviral pre-exposure prophylaxis prevents vaginal transmission of HIV-1 in humanized BLT mice. PLoS Med (2008) 5.81
Humanized mice mount specific adaptive and innate immune responses to EBV and TSST-1. Nat Med (2006) 5.36
Intrarectal transmission, systemic infection, and CD4+ T cell depletion in humanized mice infected with HIV-1. J Exp Med (2007) 3.75
CEACAM1+ myeloid cells control angiogenesis in inflammation. Blood (2009) 1.57
Epidermal langerhans cells are dispensable for humoral and cell-mediated immunity elicited by gene gun immunization. J Immunol (2007) 1.25
Activation of virus-specific memory B cells in the absence of T cell help. J Exp Med (2004) 1.13
Priming of CD8+ and CD4+ T cells in experimental leishmaniasis is initiated by different dendritic cell subtypes. J Immunol (2009) 1.13
C60 fullerene aggregation in aqueous solution. Phys Chem Chem Phys (2013) 0.96
Leishmania major parasite stage-dependent host cell invasion and immune evasion. FASEB J (2011) 0.92
CC chemokine ligand 20 partially controls adhesion of naive B cells to activated endothelial cells under shear stress. Blood (2003) 0.88
Generation and characterization of alpha-chymase-Cre transgenic mice. Genesis (2008) 0.88
CD83 is a regulator of murine B cell function in vivo. Eur J Immunol (2007) 0.87
Membrane lymphotoxin contributes to anti-leishmanial immunity by controlling structural integrity of lymphoid organs. Eur J Immunol (2002) 0.87
Protective immunity and delayed type hypersensitivity reaction are uncoupled in experimental Leishmania major infection of CCR6-negative mice. Microbes Infect (2006) 0.86
Evolution of the six horse IGHG genes and corresponding immunoglobulin gamma heavy chains. Immunogenetics (2002) 0.84
Humanized mice, a new model to study the influence of drug treatment on neonatal sepsis. Infect Immun (2013) 0.84
C60 fullerene as synergistic agent in tumor-inhibitory Doxorubicin treatment. Drugs R D (2014) 0.83
Neutralization of LIGHT ameliorates acute dextran sodium sulphate-induced intestinal inflammation. Immunology (2009) 0.83
Leishmania major infection in humanized mice induces systemic infection and provokes a nonprotective human immune response. PLoS Negl Trop Dis (2012) 0.83
Migration of Salmonella typhimurium --harboring bone marrow--derived dendritic cells towards the chemokines CCL19 and CCL21. Microb Pathog (2002) 0.82
Therapeutic reactive oxygen generation. Tumori (2008) 0.81
GPER functions as a tumor suppressor in MCF-7 and SK-BR-3 breast cancer cells. J Cancer Res Clin Oncol (2014) 0.80
Myeloid-derived suppressor cell functionality and interaction with Leishmania major parasites differ in C57BL/6 and BALB/c mice. Eur J Immunol (2014) 0.80
Langerhans cells promote early germinal center formation in response to Leishmania-derived cutaneous antigens. Eur J Immunol (2014) 0.78
Epidermal inoculation of Leishmania-antigen by gold bombardment results in a chronic form of leishmaniasis. Vaccine (2006) 0.78
Complexation of C60 fullerene with aromatic drugs. Chemphyschem (2013) 0.78
Interceptor effect of C60 fullerene on the in vitro action of aromatic drug molecules. Eur Biophys J (2014) 0.77
C60 fullerene affects elastic properties and osmoregulation reactions of human lymphocytes. Eur Biophys J (2015) 0.77
Comparative study of membranotropic action of single- and multi-walled carbon nanotubes. J Biosci Bioeng (2013) 0.77
An early reduction in Treg cells correlates with enhanced local inflammation in cutaneous leishmaniasis in CCR6-deficient mice. PLoS One (2012) 0.76
Lymphotoxin-beta receptor activation on macrophages ameliorates acute DSS-induced intestinal inflammation in a TRIM30α-dependent manner. Mol Immunol (2012) 0.76
Long-term stabilization of organic solar cells using hindered phenols as additives. ACS Appl Mater Interfaces (2014) 0.75
An advanced approach for the characterization of dendritic cell-induced T cell proliferation in situ. Immunobiology (2010) 0.75
Protein antigen delivery by gene gun-mediated epidermal antigen incorporation (EAI). Methods Mol Biol (2013) 0.75